
Enfusion (ENFN) Earnings Dates & Reports
Enfusion (ENFN) Most Recent Earnings
Report DateMar 3, 2025
Period EndingQ4 2024
Est. EPS$0.06
Actual EPS$0.03
EarningsMiss
Enfusion (ENFN) Earnings
View the latest Enfusion (ENFN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Enfusion (ENFN)
Order type
Buy in
Order amount
Est. shares
0 shares
Enfusion (ENFN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Enfusion (ENFN) Latest Earnings
The value each ENFN share was expected to gain vs. the value each share gained.
Enfusion (ENFN) reported its most recent earnings on Mar 3, 2025 for Q4 2024, posting earnings per share (EPS) of $0.03. This exceeded analysts' expectations of $0.06 by 50.00%, marking a Miss.
For comparison, Enfusion reported EPS of $0.04 in the same quarter last year.
The company is expected to announce its next earnings report on 03/03/2025, with analysts projecting an EPS of $0.
Enfusion (ENFN) Earnings History
Enfusion (ENFN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Enfusion’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Nov 4, 2024 | — | — | — |
| Aug 6, 2024 | — | — | — |
| May 9, 2024 | — | — | — |
| Mar 12, 2024 | — | — | — |
Enfusion (ENFN) Earnings FAQs
Enfusion (ENFN) last reported earnings on Mar 3, 2025 for Q4 2024, posting an EPS of $0.03, which Miss the estimate of $0.06 by 50.00%.
For Q4 2024, Enfusion (ENFN) reported an EPS of $0.03, missing analysts' estimate of $0.06 by 50.00%.
For Q4 2024, Enfusion (ENFN) Miss expectations with an actual EPS of $0.03 vs. an estimated EPS of $0.06.
Following the last earnings report on Mar 3, 2025, Enfusion (ENFN)'s stock price moved — from — to —.
The next Enfusion (ENFN) earnings call is scheduled for Mar. 3, 2025, where executives will discuss financial results and outlook.